Yesterday, in the Eudald Graells Room in Ripoll, over 70 people attended the lecture given by Dr. Jordi Monés, the Medical Director of the Barcelona Macula Foundation, on the advances in research into the treatment of macular degeneration (AMD) and other diseases of the retina.
At the event, organised by the Josep Palau Francàs Foundation with the collaboration of Ripoll Council, Dr. Monés attempted to make listeners aware of the importance of prevention in many ocular diseases and above all, once they are detected, of immediate treatment so they may be cured in time.
Age-related macular degeneration (AMD) damages visual acuity and leads to difficulties in writing, reading and driving. Following years of research, the exudative (wet) variant of this pathology may be considered as a controlled chronic disease due to the application of anti-angiogenic drugs injected into the eye.
“The results which are being obtained today were unimaginable 20 years ago. However, the other variant of the disease, dry or atrophic, has no treatment and this is our scientific obsession: to discover treatments for atrophic AMD Dr. Monés said.
The Barcelona Macula Foundation devotes itself exclusively to research in order to discover treatments for the diseases which cause blindness, such as AMD, pigmentary retinosis and Stargardt’s Disease. Dr. Monés has also explained how the Foundation has made networking one of its trademarks.